Trials / Completed
CompletedNCT00605605
Vascular Endothelial Protection Effects of Dextromethorphan
Anti-Inflammation & Vascular Endothelial Protection Effects of Dextromethorphan on Heavy Smoker
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- National Cheng-Kung University Hospital · Academic / Other
- Sex
- Male
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To test the hypothesis that DM could have anti-inflammatory effect and thus achieve vascular protection effect on heavy smokers.
Detailed description
Dextromethorphan (DM), an ingredient widely used in antitussive remedies, had been reported to reduce the inflammation-mediated degeneration of neurons. We recently found that DM can prevent vascular remodeling and neuron injury in animal models of carotid ligation and cerebral ischemia injuries, respectively. It was believed that its action was through the anti-oxidant and NADPH pathway to protect brain cells. However, the mechanism and actual effect on human vascular protection remained unclear. To test the hypothesis that DM could have anti-inflammatory effect and thus achieve vascular protection effect on heavy smokers, this prospective study will be conducted to treat subjects with heavy smoking history with DM or not and evaluate the anti-inflammatory and the improvement of endothelial function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dextromethorphan | 120 mg/day, single once daily dose taken after breakfast by oral route |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2008-01-31
- Last updated
- 2008-01-31
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00605605. Inclusion in this directory is not an endorsement.